In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Abeona Therapeutics Inc’s stock clocked out at $4.58, up 1.33% from its previous closing price of $4.52. In other words, the price has increased by $1.33 from its previous closing price. On the day, 1.43 million shares were traded. ABEO stock price reached its highest trading level at $4.63 during the session, while it also had its lowest trading level at $4.46.
Ratios:
To gain a deeper understanding of ABEO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.61 and its Current Ratio is at 5.61.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 30, 2024, initiated with a Buy rating and assigned the stock a target price of $21.
On November 11, 2020, Cantor Fitzgerald Upgraded its rating to Overweight which previously was Neutral but kept the price unchanged to $4.
On September 18, 2020, B. Riley FBR started tracking the stock assigning a Buy rating and target price of $5.B. Riley FBR initiated its Buy rating on September 18, 2020, with a $5 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 18 ’24 when Alvino Mark sold 25,890 shares for $4.51 per share. The transaction valued at 116,764 led to the insider holds 36,926 shares of the business.
Silverstein Christine Berni sold 25,821 shares of ABEO for $116,453 on Jun 18 ’24. The Director now owns 62,063 shares after completing the transaction at $4.51 per share. On May 16 ’24, another insider, Alland Leila, who serves as the Director of the company, bought 11,000 shares for $4.71 each. As a result, the insider paid 51,799 and bolstered with 82,857 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABEO now has a Market Capitalization of 187609168 and an Enterprise Value of 149456896. For the stock, the TTM Price-to-Sale (P/S) ratio is 53.60. Its current Enterprise Value per Revenue stands at 42.702 whereas that against EBITDA is -3.09.
Stock Price History:
Over the past 52 weeks, ABEO has reached a high of $9.01, while it has fallen to a 52-week low of $2.83. The 50-Day Moving Average of the stock is -5.52%, while the 200-Day Moving Average is calculated to be -11.51%.
Shares Statistics:
It appears that ABEO traded 705.18K shares on average per day over the past three months and 548950 shares per day over the past ten days. A total of 40.96M shares are outstanding, with a floating share count of 39.54M. Insiders hold about 3.46% of the company’s shares, while institutions hold 50.08% stake in the company. Shares short for ABEO as of 1715731200 were 3019896 with a Short Ratio of 3.24, compared to 1713139200 on 2061402. Therefore, it implies a Short% of Shares Outstanding of 3019896 and a Short% of Float of 7.580000000000001.
